FDA Inspection 1023640 — Todd M. Gierman, PhD
The FDA completed an inspection of Todd M. Gierman, PhD on July 14, 2017 in San Marcos, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 14, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- San Marcos, TX (United States)
Additional Details
Clinical Investigator (CI)